Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC 365

Consensus and Position Papers on Cardiovascular Pharmacotherapy

ESC Working Group on Cardiovascular Pharmacotherapy

Date

Title

Date: 2022

Title: Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Date: 2021

Title: Challenges in Cardiovascular Pharmacogenomics Implementation: A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Date: 2021

Title: Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy
Date: 2021

Title: Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Date: 2021

Title: The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Date: 2020

Title: Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension Renata Cífková, Mark R Johnson, Thomas Kahan, Jana Brguljan, Bryan Williams ... European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 6, November 2020, Pages 384–393
Date: 2020

Title: An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome
Date: 2019

Title: Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology.
Date: 2018

Title: Management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors
Date: 2018

Title: Antiarrhythmic drugs–clinical use and clinical decision making
Date: 2017

Title: Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Date: 2016

Title: Myocardial infarction with non-obstructive coronary arteries
Date: 2016

Title: Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs
Date: 2015

Title: Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management
Date: 2015

Title: Gender differences in the effect of cardiovascular drugs
Date: 2013

Title: Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
Date: 2013

Title: The use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

2022 Sex differences in arterial hypertension: A scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professions, the ESC Council for Cardiology Practice, and the ESC Working Group on Cardiovascular Pharmacotherapy